Glupen Tablet 4 mg (Glymepiride)
Glimepiride 4mg
Tablet · Prescription medication
Phamgen Science Co., Ltd.
MFDS item code 202002740 · Approved 2020.04.17
This product's status changed to Expired on 2025.04.17. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used to enhance blood sugar control in patients with type 2 diabetes as an adjunct to diet and exercise therapy. It can be used alone, or in some cases, in combination with oral hypoglycemic agents or insulin. Particularly, it is used alongside metformin in cases where blood sugar control is difficult with monotherapy of sulfonylureas or metformin. This effectively improves blood sugar control.
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. Administer this medicine orally once daily. This medicine should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose determination For patients who have not previously received drug therapy, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, there is little additional benefit at doses above 4 mg, but some patients have achieved better metabolic control with doses increased to 6 mg (or 8 mg). If treatment with 4 mg once daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control improves during treatment, the amount of this medicine needed may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, changes in lifestyle, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral glucose-lowering agent to this medicine There is no exact dose equivalence between this medicine and other oral glucose-lowering agents. When switching from another oral glucose-lowering agent to this medicine, it is recommended that the approach described under Initial Dose be followed. That is, initiate treatment at 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. The potency and duration of action of the previously administered drug should be taken into account. 4) Dose adjustment during treatment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia can be promptly controlled by immediately taking sugar. Hypoglycemia may recur even after it has been successfully managed initially during treatment with a sulfonylurea. Therefore, patients should be carefully monitored. Severe hypoglycemia requires immediate treatment and follow-up by a physician and may sometimes require hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure, and should be used when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal. Initiate insulin at a low dose and increase it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin doses should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, the addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each drug. However, efforts should be made to determine the minimum effective dose of each drug for blood glucose control. There is a risk of hypoglycemia when this medicine is administered with metformin, and the risk may increase. Appropriate precautions should be taken.
This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or severe liver or kidney dysfunction. Additionally, patients who are allergic to this medication, its components, or sulfonylurea drugs should not take it. It is preferable for pregnant or breastfeeding women not to use this medication, and it is advised to switch to insulin therapy if necessary. Patients with severe infections or those undergoing pre- or post-surgery or those who have suffered severe trauma should also be recommended to switch to insulin treatment instead of this medication. Patients with gastrointestinal disorders should be cautious due to the risk of hypoglycemia caused by food absorption issues. Patients with lactose intolerance or certain genetic metabolic disorders should not take it due to the lactose contained in this medication. During the first week of taking this medication, there is a high risk of hypoglycemia, so blood sugar levels should be monitored closely. Especially in elderly patients, those with poor nutritional status or irregular meals, frequent alcohol consumers, and patients with reduced liver or kidney function require extra caution. Additionally, there may be an increased risk of hypoglycemia in patients with other endocrine disorders or taking multiple medications, so consultation with a doctor is essential. This medication can cause hypoglycemia, which may present symptoms such as headaches, severe hunger, dizziness, confusion, drowsiness, and loss of consciousness, so these symptoms should prompt immediate intake of sugar or notification to healthcare personnel. In the initial phase, symptoms like blurred vision or dyspepsia, liver dysfunction, blood abnormalities, or allergic reactions may occur, and contact with a specialist should be made if any abnormal symptoms arise. When taking this medication, maintaining regular meals, exercise, and weight management is important, and preparations should be made to immediately consume sugar in case of hypoglycemia. Both patients and their families should fully understand the symptoms and prevention of hypoglycemia. Additionally, special situations such as stress, surgery, or infections may impair blood sugar control, and insulin therapy may sometimes need to be transitioned. When taking this medication with other drugs, the effectiveness of this medication may change, so all other medications being taken should be disclosed to doctors or pharmacists, and attention should be paid to drug interactions. Particularly, concomitant use with beta-blockers, antibiotics, anticoagulants, or steroids may cause significant changes in blood sugar. In cases of overdose, severe hypoglycemia can occur, necessitating immediate emergency treatment, including inducing vomiting, administering activated charcoal, or intravenous glucose. This medication has not been shown to be safe and effective for children, and dosage adjustments may be necessary for the elderly considering kidney function decline. Finally, this medication should be stored out of reach of children and kept in its original container, and rare but serious side effects have been reported in clinical trials and post-marketing surveillance, so immediate consultation with healthcare personnel should be made for any abnormal symptoms.
Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggression, decreased concentration, decreased agility or initiative, depression, confusion, speech abnormalities, aphasia, visual impairment, tremors, incomplete paralysis, sensory disturbances, dizziness, weakness, loss of self-control, temporary mental confusion, convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and moist skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, feelings of fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, biliary secretion disorders, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, neutropenia, agranulocytosis, pancytopenia, itching, urticaria, rash, dyspnea, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, taste disturbances, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, dyspepsia, facial edema, erectile dysfunction, flushing, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it is important to store it in a tightly closed container. Additionally, it should be stored at room temperature, neither too cold nor too hot, specifically between 1 to 30 degrees Celsius. This will help maintain the medication's effectiveness and safety.
Pale blue rectangular tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Glimepiride 4mg
Tablet · Prescription medication
Phamgen Science Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.